Earnings week: Micron, Nike, Accenture and a completely empty Friday

FQ4 + FY2026, ended Jul 31

IDT raised FY2026 adjusted EBITDA guidance to $150M to $152M on June 3, so the Q4 print is a check on whether the three growth segments carried it there. NRS recurring revenue grew 22% and BOSS Money digital revenue 27% last quarter, while the legacy BOSS Revolution calling business shrank 16%; that mix shift is the whole thesis, and the stock is up 32% this year on it. No sell-side consensus exists on Zacks or Nasdaq, so there is no Street bar to beat and the reaction will be set against the company's own guide.

Q3 revenue rose 5% to $315.7M with a record 38.8% gross margin; non-GAAP EPS was $0.94 and the company held $251.4M of cash and securities with no debt.

FQ3 2026, ended Aug 31

Consensus: EPS $1.04 (est.) · Rev $2.21B (est.) (Zacks, 2026-09-23; only ~6 analysts cover it)

The quarter itself is the smaller story. In September a fund run by a Jefferies subsidiary obtained a UK freezing order against an iron-ore trader, with reported fund-level exposure up to $499M. Jefferies has filed nothing and posted nothing for three weeks, which contrasts sharply with how it handled First Brands. Note the timing: FQ3 ended Aug 31, so this broke in FQ4 — Monday is a disclosure question, not a Q3 earnings question.

Last print fell 9.15% the next session on a vendor-consensus miss of only about 5%. In a name with six analysts the vendor number is not the real bar.

FQ4 + FY2026, ended Jul 31

Consensus: EPS -$5.37 (est.) · Rev $270.1M (est.) (Zacks, 2026-09-25; 6 analysts on EPS, 5 on revenue. Q4 is the seasonal loss quarter, so the EPS line is the smaller story.)

This is the fiscal year-end print, and the number that matters is not in the quarter. Vail cut FY2026 Resort Reported EBITDA guidance to $735M to $755M on June 8 after a winter it called one of the most challenging in history, with Q3 visitation down 15%. Season pass units for 2026/27 were down about 10% through May 26, and the CEO said the September release would carry the fall pass update and management's view of next season, which makes it the first real read on whether the pass base recovers after a bad-snow year. Net debt was 3.5x trailing EBITDA at April 30, and a September 11 release marked the close of the board nominations window with a director search still open.

Q3 Resort Reported EBITDA fell 9.5% to $586.4M and net income to $314.4M from $389.7M. Lift revenue held to a 5% decline against 15% lower visitation because pass sales were locked in before the snow failed.

FQ3 2026, Jun-Aug

Consensus: EPS $1.36 adjusted (est.) · Rev $8.36B (est.) (Zacks, 2026-09-24)

Consensus sits exactly on company guidance, so the quarter is effectively pre-announced and the revision is the story. The live variable is unhedged fuel: Carnival set guidance at spot Brent of $77.08 on June 23, and Brent was $106.60 on September 24. Against an implied Q4 of roughly $0.26 a share, a fuel overshoot of that size is material.

Beat by about 21% and still fell 4.87%. It has beaten and sold off on each of the last two prints. Made a fresh 52-week low intraday on September 24.

FQ2 FY2027, ended Aug 31

Consensus: EPS $0.67 (est.) · Rev $7.05B (est.) (Zacks, 2026-09-24)

CarMax has spent two quarters deliberately cutting gross profit per unit to buy volume, and the volume has not arrived: comps were -1.9% then -0.8%. This is the first clean read, because the year-ago quarter was the post-tariff-pull-forward hangover with comps at -6.3%. If units do not inflect against that easy base with margin already sacrificed, the strategy is failing.

Beat by about 35 cents and fell 8.98% on the day, then rose 13.14% the next session. Anyone describing that as a 9% drop is describing a move that fully reversed within 24 hours.

FY2026, ended Jul 31

Consensus: EPS -$0.04 (est.) · Rev $9.0M (est.) (Zacks, 2026-09-25; a single analyst forms both numbers, so the estimate carries little information.)

This is a full-year 10-K print for a company that chose not to sell any inventory in Q3, holding 1,456,000 pounds of U3O8 valued at $127M on April 30 and $794M of liquid assets with no debt. What the numbers can show is the production ramp: Burke Hollow started production on April 8, and management said new header houses at Christensen Ranch would lift Q4 output and bring down the $54.61 per pound total cost reported in Q3. The stock is down 53% from its 52-week high, so the print lands on a name the market has already re-rated.

Q3 produced 32,195 pounds at Christensen Ranch at a total cost of $54.61 per pound, up from $44.14 the prior quarter on approval timing and higher Wyoming taxes. The company sold nothing and kept its inventory unhedged.

FQ1 FY2027, ended Aug 31

AAR set its own bar on July 21: Q1 FY2027 sales growth of 21% to 23% excluding the Legacy Commercial Programs wind-down, with an adjusted EBITDA margin of 12.25% to 12.75%. Net leverage was 2.03x on $816M of net debt at May 31 after a fiscal-2026 equity raise lifted the diluted share count from 35.6M to 39.6M, which is why margin, not sales, is the number to hold the company to. This is also the first quarter reported under the new four-segment structure, so year-ago comparisons come recast.

Q4 FY2026 sales rose 23% to $928M and adjusted EPS 32% to $1.53, with Parts Supply up 39%; adjusted EBITDA margin was 12.5%, up 10 basis points despite the HAECO Americas dilution.

FQ3 2026, ended Aug 31

Consensus: EPS $2.71 non-GAAP (est.) · Rev $2.48B (est.) (Zacks, 2026-09-25; 2 analysts on EPS, 1 on revenue. Company guidance is $2.65 to $2.77 and $2.465B to $2.490B.)

Concentrix guided Q3 revenue of $2.465B to $2.490B, which is 0% to 1% constant-currency growth, and non-GAAP EPS of $2.65 to $2.77, so the quarter is boxed in and the margin line is the read. Non-GAAP operating margin slipped 70 basis points to 11.9% last quarter, and the company bought back no stock despite $396.6M of remaining authorization, a choice that stands out for a stock down a third this year. The question the print answers is whether AI is deflating the seat-based revenue base faster than the iX Suite deals, up 400% year over year, can replace it.

Q2 revenue grew 1.9% reported and 0.6% in constant currency to $2.46B; non-GAAP EPS fell to $2.63 from $2.70 while cash from operations hit a second-quarter record of $258M.

FQ1 FY2027

Consensus: EPS $0.31 adjusted (est.) · Rev $2.59B (est.) (Zacks, 2026-09-25; 5 analysts on EPS, 4 on revenue. Year-ago adjusted EPS was $0.39.)

Conagra reset everything on July 15: fiscal-2027 guidance of organic sales down 3% to down 1%, adjusted operating margin of 10.0% to 10.5%, adjusted EPS of $1.40 to $1.50, and a dividend cut in half to $0.70 annualized. Q1 is the first quarter under new CEO John Brase and the first against that reset, with consensus at $0.31 versus $0.39 a year ago. Adjusted gross margin fell 130 basis points to 24.5% in Q4 on input inflation and lost operating leverage; whether it is still falling is the number.

Q4 organic sales were flat with volume down 1.6% and adjusted EPS was $0.47. The GAAP result was a $3.37 per share loss on $2.0B of goodwill and brand impairments the company said were triggered by its own share price decline.

FQ1 FY2027

Cal-Maine's fiscal Q1 covers June through August, which the company itself calls one of the two seasonally weakest pricing periods, and it follows a Q4 in which conventional egg prices fell 70.9% year over year to what management called historically low inflation-adjusted levels. There is no guidance and no published consensus, so the year-ago EPS of $4.12 is the only public reference and any comparison to it is against a shortage-driven price spike. The number that shows whether the strategy is working is the share of sales from Specialty Shell Eggs and Prepared Foods, which reached 53.0% in Q4 under the new segment reporting.

Q4 net sales halved to $552.6M and the company lost $0.76 per share against $7.01 a year earlier. Conventional Shell Eggs ran at a negative 19.3% operating margin while Prepared Foods earned 14.6%.

FQ4 FY2026, ending Aug 31

Consensus: EPS $4.32 adjusted (est.) · Rev $628.2M (est.) (Zacks, 2026-09-25; 7 analysts on EPS, 6 on revenue. Full-year consensus of $17.77 sits above the top of the company's $17.25 to $17.75 guide.)

FactSet reaffirmed fiscal-2026 adjusted EPS of $17.25 to $17.75 on July 1, and the Zacks full-year consensus is $17.77, above the top of the range, so the Street is already pricing a beat before the print. Organic ASV grew 7.1% and Q3 renewals ran 30% longer on average, but adjusted operating margin fell to 34.0% from 36.8% on compensation and technology spend, and fiscal 2027 guidance is what the stock trades on. That guidance comes from a CFO who has been in the seat since April 13, with an Investor Day set for November 10 and the BCC Group acquisition closed on September 22.

Q3 revenue rose 6.4% to $622.9M with adjusted EPS up 6.1% to $4.53; GAAP EPS fell to $3.50 on one-time compensation charges, and organic ASV added $35.4M in the quarter.

FQ4 + FY2026, ended Aug 31

Consensus: EPS $4.05 core (est.) · Rev $9.61B (est.) (Zacks, 2026-09-25; 5 analysts on EPS, 4 on revenue. Company guidance is $3.80 to $4.20 and $9.2B to $10.0B.)

Jabil already guided Q4 revenue of $9.2B to $10.0B and core EPS of $3.80 to $4.20, and consensus sits inside both ranges at $9.61B and $4.05, so the quarter itself is boxed in. The same morning is billed as an investor briefing, which makes the first fiscal-2027 outlook the real event: Zacks already has FY2027 revenue at $42.2B, roughly 21% above the $35B fiscal-2026 outlook, and that number has to be met or walked back on the call. Management cited AI infrastructure demand as the driver in June and raised the full-year core margin target to 5.8%.

Q3 revenue was $8.8B with core EPS of $3.16 against GAAP EPS of $2.59. The company raised its fiscal-2026 outlook to $35B of revenue, $12.70 core EPS and $1.4B-plus of adjusted free cash flow.

FQ3 2026

Consensus: EPS $0.13 (est.) · Rev $83.1M (est.) (Zacks, 2026-09-25; 2 analysts. Year-ago EPS was $0.09.)

Bassett has two covering analysts, so the bar is a consensus of $0.13 against $0.09 a year ago on revenue of about $83M. Written sales rose 9.5% and wholesale orders 5.2% in Q2, with the Memorial Day event up 14%, and management said those trends continued into June; Q3 shows whether written orders converted into delivered revenue. The retail segment ran a 0.2% operating margin on $55.5M of sales, so any profit improvement has to come from there or from the $1.5M to $2M annual cost plan the company said would be fully realised by year end.

Q2 revenue slipped 0.7% to $83.8M and diluted EPS was $0.24 against $0.22; gross margin rose 90 basis points to 56.5% and the quarter generated $7.4M of operating cash.

FQ4 FY2026, a 14-week quarter ended Sep 3

Consensus: EPS $31.30 to $31.48 non-GAAP (est.) · Rev $50.6B to $51.1B (est.) (Benzinga Pro 2026-09-22 and S&P Global via stockanalysis.com 2026-09-25)

FQ4 is largely pre-announced by Micron's own guidance of $50.0B plus or minus $1.0B. The real variable is the Strategic Customer Agreements: Micron has capped its own realised price on roughly 40% of revenue at calendar-Q2 market levels in exchange for floors. Spot memory going higher from here converts into less upside as that ceiling binds. The CFO already flagged 'a meaningful moderation in the rate of price increases.'

Revenue of $41.46B in one quarter exceeded all of fiscal 2025 at $37.38B, at an 84.6% gross margin. The stock rose 15.74% the next session and set its 52-week high that same day, and has not reclaimed it since.

FQ3 2026, ended Aug 31

Consensus: EPS $1.49 non-GAAP (est.) · Rev $247.2M (est.) (Zacks, 2026-09-25; 2 analysts. The consensus sits below the company's own $1.53 to $1.59 guide.)

Progress guided Q3 revenue of $244M to $250M and non-GAAP EPS of $1.53 to $1.59 on June 30, and the two-analyst consensus of $1.49 sits below the bottom of that range. The bigger item is the $400M acquisition of Domo's AI and data platform business, completed on September 22 and funded with cash and the revolver, on a balance sheet that was already at 2.9x net leverage with $103M of cash at the end of May. Management said the financial impact would be laid out on the September 30 call, so the leverage and accretion math is the event, not the quarter.

Q2 revenue grew 7% to $253M with non-GAAP EPS of $1.62 against $1.40, but ARR grew only 2% and net retention was 100%. Software licence revenue jumped 36% while maintenance and SaaS revenue fell 1%.

FQ4 + FY2026, ended Aug 31

Consensus: EPS $3.18 (est.) · Rev $18.04B (est.) (TipRanks and Zacks, 2026-09-25)

Accenture stopped disclosing a GenAI bookings figure after Q1 FY2026, so there is no current number to compare and anyone quoting $2.2B is two quarters stale. What actually matters is first-time FY2027 guidance and its organic component: management has said inorganic growth will be slightly below 2%, so a headline 2-5% guide implies roughly 0-3% organic. Consulting grew 1% against managed services at 5%, and that four-point spread is the strongest evidence in the company's own release for AI deflating consulting pricing.

Beat on EPS, missed slightly on revenue, and fell 17.97% the next session, gapping down and never filling it.

FQ4 + FY2026, ended Aug 31

Consensus: EPS $5.67 adjusted (est.) · Rev $1.26B (est.) (Zacks, 2026-09-25; 4 analysts. Year-ago adjusted EPS was $5.20. The company gives no quarterly guidance.)

Acuity gave no guidance with its Q3 release, so fiscal Q4 is graded on a consensus of $5.67 against $5.20 a year ago. The split inside the company is the story: Acuity Brands Lighting sales fell 1.9% to $905M with adjusted margin down 60 basis points, while Intelligent Spaces grew 14.9% to $304M at a 25.1% adjusted margin, so the growth is coming from the segment that is a quarter the size. Nine-month operating cash flow was $520.2M and the company had spent $230M on buybacks, which is where the EPS growth has been coming from as much as from operations.

Q3 net sales rose 1.6% to $1.2B and adjusted EPS 3.7% to $5.31; adjusted operating margin was 18.7%, down 10 basis points, with $6.4M of tariff refunds excluded from the adjusted figures.

FQ3 2026, ended Aug 31

Consensus: EPS $0.75 adjusted (est.) · Rev $1.98B (est.) (Zacks, 2026-09-25; 6 analysts on EPS, 4 on revenue. Year-ago adjusted EPS was $0.85.)

McCormick reaffirmed fiscal-2026 adjusted EPS of $3.05 to $3.13 and organic growth of 1% to 3% on June 25, and Q3 consensus is $0.75 against $0.85 a year ago, so the Street already has the quarter down. The pressure point is Consumer Americas, where volume and mix fell 3.6% last quarter while reported growth of 16.7% came almost entirely from consolidating McCormick de Mexico. The proposed Unilever Foods combination sits over everything, and the stock is down about 30% this year going into the print.

Q2 adjusted EPS rose to $0.80 from $0.69 on a 270 basis point gross margin gain, 140 points of which was a one-time $28M IEEPA tariff refund. Organic sales grew 1.7%, all of it price.

FQ1 FY2027, ended Aug 31

Consensus: EPS $0.44 (est.) · Rev $11.41B (est.) (Zacks, 2026-09-24. Nike gave no Q1 EPS guidance at all, so the EPS figure is entirely a Street construct.)

Consensus revenue sits at or above the top of Nike's own guided range of down low-to-mid single digits. The real issue is the gross-margin inflection management deliberately pulled forward into Q1 while trading revenue away for it, so a revenue miss is partly by design. Two things are widely missed: a new CFO took over on August 17 and this is his first call, and the Win Now programme is being retired at an Investor Day in November. A new CFO six weeks before a strategy reset has both the incentive and the cover to guide conservatively.

Last quarter's $0.72 EPS included a $0.52 tariff-recovery benefit, so adjusted was $0.20, and the 49.2% gross margin was 40.2% excluding that benefit. The stock rose 4.90% the next session. It goes into this print about 1.8% off its 52-week low.